A multicenter study of the detection rate for prostate cancer according to the serum prostate-specific antigen level in Korean men

Korean Journal of Urology

Volumn 46, Issue 5, 2005, Pages 433-437

  Lee, Dong Hyeon ^l   Yang, Won Jae ^a   Chung, Byung Ha ^a   Kim, Sun Il ^b   Kim, Se Joong ^c   Kim, Young Sig ^d   Kim, Hong Sup ^e   Seong, Do Hwan ^f   Song, Jae Man ^g   Yang, Seung Choul ^a   Cheon, Sang Hyeon ^h   Cho, In Rae ⁱ   Cho, Jin Seon ^j   Choi, Young Deuk ^a   Hong, Sung Joon ^a   Kim, Chun Il ^k  

^a Yonsei University   (South Korea)

^b Hanyang University   (South Korea)

^c Ajou University   (South Korea)

^d National Health Insurance Corporation   (South Korea)

^e Konkuk University   (South Korea)

^f Inha University   (South Korea)

^g Yonsei University Wonju   (South Korea)

^h University of Ulsan   (South Korea)

ⁱ Inje University   (South Korea)

^j Hallym University   (South Korea)

^k Keimyung University   (South Korea)

^l Ewha Womans University School of Medicine   (South Korea)

more..

Author keywords

Biopsy; Detection; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER INCIDENCE; CONTROLLED STUDY; HEALTH CARE FACILITY; HUMAN; INTESTINE EXAMINATION; KOREA; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY; REVIEW; UNITED STATES;

EID: 20344377854     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17: 159-63
2. Brawley OW. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer 1997;80:1857-63
3. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol 1999;162:293-306
4. Stephenson RA. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am 2002;29:173-81
5. Myrtle J, Ivor L. Measurement of PSA in serum by two immunometric method (Hybritech Tandem-R/Tandem-E PSA). In: Catalona WH, Coffey DS, Karr JP, editors. Clinical aspects of prostate cancer: assessment of new diagnosis and management procedures. New York: Elsevier; 1989;161-71
6. Catalona WJ, Hudson MA, Scardino PT, Richie JP, Ahmann FR, Flanigan RC, et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994;152:2037-42
7. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. 7th ed. Lyon: International Agency for Research on Cancer; 1997;1-35
8. Jung BC, Kim TH, Jeong SJ, Kwak C, Lee SE. The clinical usefulness of the prostate-specific antigen density, digital rectal examination, and transrectal ultrasonography in the screening test of prostate cancer in Koreans. Korean J Urol 2002;43:14-8
9. Oh JS, Yoon DK. The necessity of transrectal prostate biopsy in advanced prostate cancer: the dependence of sensitivity, specificity and positive predictive value on serum PSA level. Korean J Urol 2003;44:1256-61
10. Lee SB, Kim CS, Ahn HJ. Comparative analysis of sextant and extended prostate biopsy. Korean J Urol 2004;45:524-9
11. Lee SC, Lee SC, Kim WJ. Value of PSA density, PSA velocity and percent free PSA for detection of prostate cancer in patients with serum PSA 4-10ng/ml patients. Korean J Urol 2004;45:747-52
12. Egawa S. Detection of prostate cancer by prostate-specific antigen. Biomed Pharmacother 2001;55:130-4
13. Gretzer MB, Partin AW. PSA levels and the probability of prostate cancer on biopsy. Eur Urol 2002;43(Suppl 1):21-7
14. Jung PM, Bang JS, Park YH. Clinical observation on the transrectal needle biopsy. Korean J Urol 1979;20:603-5
15. Kim CS, Ahn TY. The role of serum prostate specific antigen in prostatic cancer and benign prostatic hyperplasia. Korean J Urol 1992;33:806-11
16. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-90
17. Schroder FH, van der Maas P, Beemsterboer P, Kruger AB, Hoedemaeker R, Rietbergen J, et al. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 1998; 90:1817-23